Evaluation of Herpes Simplex Virus Type 1 Antibody in Dental Students of Birjand University of Medical Sciences

doi:10.21203/rs.3.rs-42424/v1

PDF

Research

Evaluation of Herpes Simplex Virus Type 1 Antibody in Dental Students of Birjand University of Medical Sciences

https://doi.org/10.21203/rs.3.rs-42424/v1

This work is licensed under a CC BY 4.0 License

Version 1

posted 21 Jul, 2020

You are reading this latest preprint version

Objective: Herpes viruses are ubiquitous human pathogenswhich canall be found in the oral environment. Dental practitioners have a close relationship with many patients and are at risk of cross-infection. So, HSV-1 infectionas a potential occupational hazard for dental workers is important. The aim of this study was to determine the level of HSV1 antibody in dental students of Birjandin 2018-2019.

Methods: This descriptive cross-sectional study was performed on 100 dental students of Birjand University of Medical Sciences during a six-month period, who were selected by random cluster sampling. After taking written consent, demographic information and positive history of genital or oral lesions were recorded based on a researcher-made questionnaire. Then, a peripheral blood sample (5 ml) was taken from participants and an anti-virus antibody was examined using an Anti-Herpes-1 IgG kit with ELISA by a pathologist. Finally, the data were analyzed by SPSS 21.

Results: About half of the subjects (41%) had contact with HSV1 virus and were carrier of antibodies. The prevalence of HSV1 antibody in pre-clinical and clinical level was higher than in basic science, but there was no significant relationship between students' level of education and antibody prevalence (p = 0.77). Also, there was no significant difference in prevalence of HSV1 antibody by age, sex and marital status of students (p> 0.05).

Conclusion: The prevalence of HSV1 antibodies in this study is lower than that of European countries, which may be due to regional culture, which requires further study on different groups and more individuals

Toxicology

Occupational Medicine

Herpessimplex virus infections

cross-infection

dentistry

Herpes simplex virus (HSV) infections are among the most commoninfectious agents of humans. The natural history of HSV infection is influenced by two features of the virus (1). There are two distinct serotypes: HSV-1, which is transmitted chiefly via a non-genital route, and HSV-2, which is most often transmitted sexually or from a mother’s genital infection to the newborn; and during initial (primary) infection(2).The mode of spread of each of the two virus types is reflected by its relative prevalence at different ages and by its pattern of clinical distribution within the host. Periodically, the latent virus can be reactivated to cause symptomatic or subclinical recurrent infections. Hence, HSV infections may range from subclinical to life threatening, and the specific clinical illness will be determined by the portal of virus entry, the competence of the host immune system, and whether the infection is primary or recurrent(2,4,8). Unless resulting from autoinoculation or sexual spread from the mouth to genital sites, HSV-1 infections occur most frequently during childhood and affect most often the mouth, lips, and skin sites above the waist.

An increase in infectious diseases over the past decades has attracted worldwide attention. So that many efforts and costs is spent by the government to control these diseases.

In Iran, the prevalence of HSV1 was 42.04% and HSV2 6.5% as mentioned in a meta-analysis study(4).

Mucosal covering of the mouth, nose, ears, pharynx, anus, genitals, cervix and urinary tract are areas prone to herpes virus. HSV1 usually causes ulcers in the lips and mouth areas which are usually recurrent and painful.

The average recurrence of herpes simplex infection is 2 to 3 times each year, but it is observed up to 12 times in a year. Factors such as topical skin trauma, exposure to ultraviolet radiation, hormonal and systemic changes in the body, fever, surgery, stress and immune deficiencyare effective. Recurrent herpes labialisvirus caused to painful mucosal lesions; asit is estimated that 30% of the population affects with this problem (5).

Cross-infections are very likely to be transmitted during dental procedures due to direct and frequent contact with blood, saliva and other body fluids, and indirect contact with contaminated surfaces, as well as airborne particles.

In the recent years, despite the diseases such as hepatitis AIDS, HSV infections, it has been focused much attention on the problem of infection transmission and the antibody level of dentists and dental students due to risk of infection transmission (7).

Also, prevalence of infections in the dental profession is high,because these people are more exposed to blood, saliva and risk of sharps (8).

There are only a few reports of HSV cross-infection inthe dental practice. The frequency of herpetic whitlowwas observed to be higher among practicing dentistscompared to the normal population (9). However, reportsconfirming the transmission of infection from the patientto the dental team infection are available in the literature(8). Also the cross-infection of HSV from dental team topatients has been shown. A dental hygienist with aherpetic whitlow, who did not use gloves routinely,infected 20 out of 46 patients (10).

A large portion of the adult population is infected withHSV-1 and reactivations resulting in subclinical orsymptomatic infection are frequent. However, fewresearchesare published on the cross-transmission andinfection of HSV-1 through the dental practice.

Adherence to safety principles is essential during dental treatment for health of the dentist, patient and clinic staff and their families. Since dental students are in close contact with patients during their education and are exposed to cross-infection, so, if the infection control principles are not adhered, the probability of transmission of HSV1 virus to themincrease through the saliva and mucus secretions of patients.

Therefore, the aim of present study was to investigate the rate of HSV1 antibody titer indental studentsof Birjand University of Medical Sciences in 2018–2019.

In this descriptive cross-sectional study, dental students of Birjand University of Medical Sciences were selected using cluster sampling method over a six-month period 2018–2019.The sample size was estimatedaccording to the following formula, in which theprevalence of HSV1 was consideredequal to 42%

Where Z² is constant, p is the prevalence and d is the estimated error risk. As result, 100 individuals, according to the student’s level, from 3 different levels (basic sciences, pre-clinical, clinical) the subjects were randomly selected as the study sample on the basis of random numberstable.After explaining about researchproject, each student completed an informed consentform. The risk factors and epidemiologicalcharacteristics were based on a review of the literature, information such as age, sex, marital status, educational level, history of genital or oral lesions and use of any antiviral orimmunosuppressive drugs were recorded based on a researcher-made questionnaire.

Peripheral blood samples(5 ml)were taken from participants. Thespecimens were placed in sterile-covered storage tubes. After serum separation, the samples were kept at -28 ° C until collection of all the samples. Then, the presence of anti-virus antibody was then evaluated by a pathologist using a dedicated Anti-Herpes-1 IgG kit and by an Enzyme-Linked Immunosorbent Assay (ELISA) method.Experienced technicians performed the blood sampling,data gathering, and questionnaire administration above criteria was determined.

Statistical Analysis:

This study was approved by the ethics and scientific committee of Birjand University of Medical Sciences, Iran(approval code: bums.1394.11). The quantitative and qualitative data were analyzed using SPSS, ver. 21 (Chicago, IL,U.S.). For qualitative data, the normal distribution was assessed using the K-S test. For data with a normal distribution, the means ± standarddeviation (SD) were computed, and independent T-tests and the Mann-Whitney test were performed. Qualitative datawere described and analyzed using frequencies and prevalence, in addition to the chi-squared and fisher exact tests test. A p.value less than 0.05 was considered statistically significant.

A total of 100 dental students (43 males and 57 females) participated in the study as shown in Table 1 with mean age of 22.8 ± 3.9 years. Their age ranged from 19 to 46 years. Demographic characteristics of the studied students are presented in Table 1.

Table 1

Frequency distribution of demographic Characteristics in the Study Participants
Variable		Frequency	percentage
Sex	male	43	43
Sex	female	57	57
marital status	single	87	87
marital status	married	13	13
Educational level	Basic Sciences	33	33
	Pre-clinic	31	31
	Clinical	36	36
History of herpes	Yes	31	31
History of herpes	No	69	69
History of antiviral drugs	Yes	1	1
History of antiviral drugs	No	99	99
Antibodytiter status	Negative	59	59
Antibodytiter status	Positive	41	41

According to the results of Table 1, 31% of the studied students had a history of herpes and 1% had a history of taking antiviral drugs.

The meanof IgG titer in the studied students was 16.1 ± 17.2 with a median of 3.35, ranged from 0.8 to 45.9 and 59% of the studied students had negative antibody titer[Table 2].

Table 2

Comparison of frequency distribution of antibody titer status according to the demographic variables of the studied students
Antibody titer status Variable		Negative	Positive	Chi Square's test
fSex	male	22(51.2)	21(48.8)	λ² = 1.92, df = 1 P = 0.17
fSex	female	37(64.9)	20(35.1)	λ² = 1.92, df = 1 P = 0.17
Age	< 21	27(60)	18(40)	λ² = 0.17, df = 2 P = 0.92
	22–24	21(60)	14(40)
	> 25	11(55)	9(45)
Marital status	single	51(58.6)	36(41.4)	λ² = 0.04, df = 1 P = 0.84
Marital status	married	8(61.5)	5(38.5)	λ² = 0.04, df = 1 P = 0.84
Educational level	Basic Sciences	21(61.6)	12(36.4)	λ² = 0.52, df = 2 P = 0.77
	Pre-clinic	17(54.8)	14(45.2)
	Clinical	21(58.3)	15(41.7)
History of herpes	Yes	4(12.9)	27(87.1)	λ² = 39.5, df = 1 P < 0.001
History of herpes	No	55(79.7)	14(20.3)	λ² = 39.5, df = 1 P < 0.001

There was observed no statistically significant difference in antibody titer status by sex and age in the studied students(p > 0.05)[Table 2].

There was no statistically significant difference in the status of antibody titer according to marital status and educational level(P > 0.05).However, it was significantly lower in subjects with a history of herpesthan in students without this history (20.3% vs 87.1%)(P < 0.001) [Table 2].

According to Table 3, no statistically significant difference was observed in the mean IgG titer in terms of gender, marital status, educational level and age in the studied students(P > 0.05), but IgG antibody titer in students with a history of herpes was significantly higher than students withouta history (p < 0.001).

Table3. Comparison of IgG antibody titer mean by demographic variables in students
Antibody titer status Variable		Mean±SD	Mann-Whitney or Kruskal–Wallistest
Sex	male	17.97±2.94	Z=67 P=0.51
Sex	female	16.37±2.17	Z=67 P=0.51
Age	<21	16.1±17.42	λ²=0.53, df=2 P=0.77
	22-24	15.1±16.73
	>25	17.77±18.2
Marital status	single	16.16±17.22	Z=0.08 P=0.94
Marital status	married	15.5±17.67	Z=0.08 P=0.94
Educational level	Basic Sciences	14.59±16.77	λ²=0.09, df=2 P=0.95
	Pre-clinic	17.63±17.58
	Clinical	16.1±17.6
History of herpes	Yes	38.8±12.69	Z=5.91 P<0.001
History of herpes	No	33.2±13.1	Z=5.91 P<0.001

Infectious diseases are serious health challengeworldwide.Dueto the frequent contact of dental workers with factors such as blood and saliva of patients and because most human pathogens can be transmitted through blood andsaliva, therefore, the risk of infectious diseases among dental personnel ishigher than other people in the community and the prevention of contagion and transmission ofinfections from patients to the dental team and vice versa are important.

Researches show that the dentist and his assistant are able to inhale 0.014 microliters of the patient's salivary glands within 15 minutes of exposure to oral aerosols, so adhering to the principles of safety during dental treatment for the health of the dentist and patient, clinicsworkersand their families are needed.

Since dental students are future dentists of community, awareness of HSV1 antibody levels in students may lead to the need to provide more effective solutions to adhering to the principles of infection control for dental students.The results of this study showed that 59% of students had negative antibody titer and 41% had positive antibody titer. StudyofSorbzadeh et al,has been found 49% inblood transfusion subjects with 15–45 years old, whichillustrates same result in contrast to thisstudy (11). In mofidi's study, HSV1 antibody wasreported 44.3% (12). In study conducted by Tayebi et al, who examined HSV1 and HSV2 antibody titers in the university students, the rate of HSV1 antibody was 79.2% (13).

Various studies conducted in industrialized countries have reported different results, for example Suligoi (14), reported 51.6%on Italian people; Smithreported 90.4% on 15–65 years old people in carodinaand Michelle Howard reported 51.1% HSV1 antibody level in Canadian adults aged 15–44 years old which all of these is higher than the present study. The difference in antibody titer may be due to social situation and age groups in different parts of thesesurveys (16).

According to the results of the present study, the mean of HSV1 antibody titer in different age groups increased with age and increased from 16.1in < 21-year-old group to 17.77 in the < 25-year-old group, but this increasing trend didn't show asignificant difference between groups. Other researchers,in different countries, such as Sweden, Italy, Germany and Swiss have been reported age as aneffective factor in increasing rates of HSV1 antibody titers, which is similar to the results of this study.

Another finding of this study showed that, 35.1% of women and 48.8% of men were positive for IgG antibody. Although men accounted for a higher percentage than women,but there was no significant relationship between gender and HSV1 antibody titers. In the study of Auslander et al. [8], the prevalence of antibody was 53.1% in men and 46.9%in women, which, as the present study, it was higher in men than women.

In the study of Michael Howard et al, prevalence of antibodies was 57.7% and 42.3% in women and men respectively [16]. Also, Theng andRabenau studies reported higher prevalence of antibodies in women than men, which is not consistent with the results of this study. In the studies [11, 15, 17], there was no significant difference between gender and frequency of HSV1 antibody, which is consistent with the results of this study.

According to the results of this study, prevalence of antibody in pre-clinical and clinical students was higher than those in basic sciences, but there was no significant relationship between antibody prevalence and educational level. In the Herbert’sstudy, that examined the sero-epidemiology of herpesvirus among dental workers and students, there was no significant difference between HSV1 antibody and educational level, but antibody level in clinical students was higher than pre-clinical level. The reason is probably due to more contacts of these students' with patients[22].

The results showed no significant difference between prevalence of HSV1 and marital status, so that the result of mofidi's study is similar to the present study.

Rezai et al. who investigated the sero-epidemiology of HSV1 and HSV2, reported marital status as an effective factor on HSV1 antibody levels[23], which is inconsistent with the results of this study. In the present study, 20.3% of people who did not have herpes had positive antibody titer. Becausewho with anti-HSV antibody may have received oral HSV infection during childhood,but they did not recur and therefore did not report a history of herpes.

The results of this study should alert all dentists of future dental care providers to consider how their students are educated about providing care for patients with HSV infections and, more importantly, patients with infectious and communicable diseases in general. Specifically, this study showed thatabout half of the subjects have contact with HSV1 virus and carry the antibody.There was no significant difference between the prevalence of HSV1 antibody in terms of age, sex and marital status of students. In summary,Addressing students’ apprehensions might be a crucial moderator that will determine whether they will provide the best possible care for these patients in their future professional lives.

It is recommended to design studies to increase students' awareness of the principles of infection control when dealing with people with herpes simplex. It also recommended that studies be designed wider and with more samples.

Ethics approval and consent to participate

This study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving research study participants were approved by the Birjand University of Medical Sciences ethics board committee, reference number: IR.BUMS.REC.1398.324. Written informed consent was obtained from all participants and questionnaires were anonymous and encoded. For the participants, all processes were free of charge.

Consent for publication

All authors read the content of this study and approved for publication

Availability of data and materials

It will be available to the corresponding author upon reasonable request

Competing interests

None

Funding

None

Authors' contribution

Dr.parvayi and Dr.zardast designed and performed the research study analyzed the data and wrote the paper. Dr.Parvayi designed the research study;Dr.Ebrahimian analyzed the data and wrote the paper. Dr.Osmani, designed the research study and analyzed the data and wrote the paper. S.ebrahimian contributed to the data collection and wrote the paper. All authors critically reviewed the manuscript and authorized the final version of the paper.

Acknowledgements

We would like to thank all the study subjects for their participation and extend our thanks to Dentistry Clinical Research Development Center, Birjand University of Medical Sciences for providing bedding to sample collection.

Molinari, J.A., Dental infection control at the year 2000: accomplishment recognized. Journal of the American Dental Association (1939), 1999. 130(9): p. 1291-1298.
Shillitoe, E.J., et al., Neutralizing antibody to herpes simplex virus type 1 in patients with oral cancer. Cancer, 1982. 49(11): p. 2315-2320.
Sauerbrei, A., et al., Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006. Eurosurveillance, 2011. 16(44): p. 20005.
Malary, M., et al., The prevalence of herpes simplex virus type 1 and 2 infection in Iran: A meta-analysis. International Journal of Reproductive BioMedicine, 2016. 14(10): p. 615.
Baghian, A., et al., Protective immunity against lethal HSV-1 challenge in mice by nucleic acid-basedimmunisation with herpes simplex virus type-1 genes specifying glycoproteins gB and gD. Journal of medical microbiology, 2002. 51(4): p. 350-357.
Moshkelgosha, V. and R. Monirifard, An epidemiological study of recurrent herpes labialis in the population of Isfahan in 2002 (Dissertation). Isfahan: School of Dentistry, Isfahan University of Medical Sciences, 2003.
Palenik, C.J., F. Trevor Burke, and C.H. Miller, Strategies for dental clinic infection control. Dental update, 2000. 27(1): p. 7-15.
Stevenson, A.R. and T.J. Higgins, Infection Control in general dental practice: results of a postal survey of 600 registered dental practitioners in New South Wales. Australian dental journal, 1989. 34(2): p. 106-114.
Kanjirath, P.P., M.C. Peters, and M.R. Inglehart, Treating patients with herpes simplex virus infections: dental and dental hygiene students’ knowledge, attitudes, and professional behavior. Journal of dental education, 2007. 71(9): p. 1133-1144.
Brooks, S.L., et al., Prevalence of herpes simplex virus disease in a professional population. The Journal of the American Dental Association, 1981. 102(1): p. 31-34.
Arabzadeh, A., et al., The prevalence of HSV2 antibodies in Blood Transfusion Department (2002) from university of medicalsciences. Journal of Kerman University of Medical Sciences, 2003. 10(1).
Hedayat Mofidi, M., et al., Sero-epidemiological Study of Herpes simplex virus type 1 infections in outpatient population referred to clinical laboratories in Gorgan, IRAN 2006.Medical Laboratory Journal, 2008. 2(1): p. 0-0.
TAYEBI, D. and E. SHARIFI, Seroepidemiology of infection with herpes simplex virus types 1 and 2 (HSV1 and HSV2) among asymptomatic university students attending Islamic Azad University of Kazeroun, southwest of Iran. 2010.
Suligoi, B., et al., Seroprevalence and seroincidence of herpes simplex virus type 1 and herpes simplex virus type 2 infections in a cohort of adolescents in Italy. Sexually transmitted diseases, 2004. 31(10): p. 608-610.
Smith, J., et al., Type specific seroprevalence of HSV-1 and HSV-2 in four geographical regions of Poland. Sexually transmitted infections, 2006. 82(2): p. 159-163.
Howard, M., et al., Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada. Journal of clinical microbiology, 2003. 41(1): p. 84-89.
Tunbäck, P., et al., Prevalence of herpes simplex virus antibodies in childhood and adolescence: a cross-sectional study. Scandinavian journalof infectious diseases, 2003. 35(8): p. 498-502.
Wutzler, P., et al., Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations—relevance for the incidence of genital herpes. Journal of medical virology, 2000. 61(2): p. 201-207.
Rabenau, H., et al., Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany. Medical microbiology and immunology, 2002. 190(4): p. 153-160.
Bünzli, D., et al., Seroepidemiology of Herpes Simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25–74 in 1992–93: a population-based study. BMC infectious diseases, 2004. 4(1): p. 10.
Theng, C.T., et al., Seroprevalence of herpes simplex virus-1 and-2 in attendees of a sexuallytransmitted infection clinic in Singapore. Sexual health, 2006. 3(4): p. 269-274.
Herbert, A.-M., et al., Seroepidemiology of herpes virus infections among dental personnel. Journal of dentistry, 1995. 23(6): p. 339-342.
Rezaei-Chaparpordi, S., et al., Seroepidemiology of Herpes Simplex Virus Type 1 and 2 in Anzali city 2010-2011. Zahedan J Res Med Sci, 2012. 14: p. 67-69.

PDF

Version 1

posted 21 Jul, 2020

You are reading this latest preprint version

Evaluation of Herpes Simplex Virus Type 1 Antibody in Dental Students of Birjand University of Medical Sciences

Status:

Version 1

Abstract

Introduction

Materials And Methods

Statistical Analysis:

Results

Discussion

Conclusions

Declarations

Ethics approval and consent to participate

Consent for publication

Availability of data and materials

Competing interests

Funding

Authors' contribution

Acknowledgements

References

Status:

Version 1